Brief Article
Copyright ©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. May 14, 2013; 19(18): 2811-2817
Published online May 14, 2013. doi: 10.3748/wjg.v19.i18.2811
Prognostic value of preoperative mean corpuscular volume in esophageal squamous cell carcinoma
Yu-Zhen Zheng, Shu-Qin Dai, Wei Li, Xun Cao, Yong Li, Lan-Jun Zhang, Jian-Hua Fu, Jun-Ye Wang
Yu-Zhen Zheng, Yong Li, Lan-Jun Zhang, Jian-Hua Fu, Jun-Ye Wang, Department of Thoracic Oncology, Cancer Center, Sun Yat-Sen University, Guangzhou 510060, Guangdong Province, China
Shu-Qin Dai, Department of Clinical Laboratory, Sun Yat-Sen University Cancer Center, Guangzhou 510060, Guangdong Province, China
Wei Li, Department of Anesthesia, Sun Yat-Sen University Cancer Center, Guangzhou 510060, Guangdong Province, China
Xun Cao, Intensive Care Unit, Sun Yat-Sen University Cancer Center, Guangzhou 510060, Guangdong Province, China
Yong Li, Department of Pathology, Sun Yat-Sen University Cancer Center, Guangzhou 510060, Guangdong Province, China
Author contributions: Zheng YZ and Dai SQ contributed equally to this work; Zheng YZ and Dai SQ drafted the article; Li W revised the manuscript; Cao X and Li Y provided the raw data; Zhang LJ and Fu JH analyzed the data; Wang JY designed the study.
Correspondence to: Jun-Ye Wang, Professor, Department of Thoracic Oncology, Cancer Center, Sun Yat-Sen University, No. 651, Dongfeng Road East, Guangzhou 510060, Guangdong Province, China. zhengyzh@sysucc.org.cn
Telephone: +86-20-87343315 Fax: +86-20-87343268
Received: December 17, 2012
Revised: March 1, 2013
Accepted: March 21, 2013
Published online: May 14, 2013
Processing time: 147 Days and 22.7 Hours
Abstract

AIM: To evaluate whether preoperative mean corpuscular volume (MCV) is a prognostic indicator in patients with resectable esophageal squamous cell carcinoma (ESCC).

METHODS: A total of 298 consecutive, prospectively enrolled patients with histologically diagnosed ESCC who underwent surgery with curative intent from 2001 to 2011 were retrospectively evaluated. Patients were excluded if they had previous malignant disease, distant metastasis at the time of primary treatment, a history of neoadjuvant treatment, had undergone non-radical resection, or had died of a non-tumor-associated cause. Survival status was verified in September 2011. Pathological staging was performed based on the 2010 American Joint Committee on Cancer criteria. Preoperative MCV was obtained from blood counts performed routinely within 7 d prior to surgery. Receiver operating characteristic (ROC) curve analysis was used to determine a cutoff for preoperative MCV.

RESULTS: The 298 patients consisted of 230 males and 68 females, with a median follow-up of 30.1 mo. ROC analysis showed an optimal cutoff for preoperative MCV of 95.6 fl. Fifty-nine patients (19.8%) had high (> 95.6 fl) and 239 (80.2%) had low (≤ 95.6 fl) preoperative MCV. Preoperative MCV was significantly associated with gender (P = 0.003), body mass index (P = 0.017), and preoperative red blood cell count (P < 0.001). The predicted 1-, 3- and 5-year overall survival (OS) rates were 72%, 60% and 52%, respectively. Median OS was significantly longer in patients with low than with high preoperative MCV (27.5 mo vs 19.4 mo, P < 0.001). Multivariate analysis showed that advanced pT (P = 0.018) and pN (P < 0.001) stages, upper thoracic location (P = 0.010), lower preoperative albumin concentration (P = 0.002), and high preoperative MCV (P = 0.001) were negative prognostic factors in patients with ESCC. Preoperative MCV also stratified OS in patients with T3, N1-N3, G2-G3 and stage III tumors.

CONCLUSION: Preoperative MCV is a prognostic factor in patients with ESCC.

Keywords: Preoperative markers; Mean corpuscular volume; Prognosis; Resectable; Esophageal neoplasms

Core tip: Elevated mean corpuscular volume (MCV) has been shown to predict the risk of esophageal squamous cell carcinoma (ESCC). We hypothesized that pretreatment MCV could predict prognosis. In analyzing 298 patients with ESCC, we found that the optimal cut-off for preoperative MCV was 95.6 fl. Multivariate analysis showed that high (> 95.6 fl) preoperative MCV was a negative prognostic factor, along with advanced stage, upper thoracic location and lower preoperative albumin, in patients with ESCC. Median overall survival was significantly longer in patients with low (≤ 95.6 fl) than high preoperative MCV (27.5 mo vs 19.5 mo, P < 0.001).